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with signi cant increases in phosphorylated forms of Akt, ERK1/2 
and their downstream target GSK-3β. At 4 wks post-STZ injection, 
rats displayed ; i) low plasma insulin levels and hyperglycemia ; ii) 
inhibition of EPO-induced cardioprotection ; iii) no up-regulation 
of PI3K/Akt, ERK1/2 and GSK-3β signalling in response to EPO. In 
contrast, at 4 wks post-HF diet, rats showed ; i) high plasma insulin 
levels and normoglycemia ; ii) cardioprotective effect of EPO (LVDP 
was 63.63±3.75 mmHg in EPO hearts vs 49.83±7.11 mmHg in Ctrl 
hearts at 30 min of reperfusion ; ρ<0.05); iii) up-regulation in PI3K/
Akt, ERK1/2 and GSK-3β signalling.
Conclusion — EPO improves post-ischemic cardiac function 
recovery in insulin resistance but not in diabetic rat hearts. Survival 
signalling pathways seem to be impaired in presence of diabetes.
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Background — Erythropoietin (EPO) and ischemic postconditioning 
(IPost) have been shown to attenuate myocardial reperfusion 
injury.
Aims: This study compared the mechanisms of the acute 
cardioprotective effect of EPO and IPost and tested whether they 
share similar signalling pathways in isolated rat hearts, focussing 
on phosphatidylinositol 3-kinase (PI3K)/Akt and ERK1/2 pathways.
Methods — Hearts were subjected to 25 min global ischemia 
followed by 30 min of reperfusion. 7 groups were tested: control 
(no intervention); IPost (3 cycles of 10 sec reperfusion/10 sec 
ischemia at the onset of reperfusion); EPO (1000 UI/kg, at the onset 
of reperfusion); IPost+PI3K inhibitor wortmannin (Wort, 1 mol/L); 
EPO+Wort ; IPost+ERK1/2 inhibitor PD98059 (PD, 10 mol/L); 
EPO+PD.
Results — IPost- or EPO-treated hearts exhibited signi cantly 
improved left ventricular function re ected by an increase in post-
ischemic recovery of left ventricular developed pressure (LVDP) 
and improved contractility (dP/dtmax) and relaxation (dP/dtmin) 
indexes throughout the reperfusion period compared with control 
hearts. EPO showed better LVDP than IPost at 30 min reperfusion 
(73.18±10.23 mmHg vs. 48.11±7.92 mmHg, ρ<0.05). Wort or PD 
fully prevented both EPO and IPost-mediated cardioprotection. 
Phosphorylation of myocardial Akt was signi cantly increased 
in both IPost and EPO groups. However, phosphorylation levels 
of ERK1/2 and the downstream target GSK-3β were signi cantly 
increased in EPO group only.
Conclusion — EPO and IPost share similar intracellular 
cardioprotective pathways. EPO exhibits better cardioprotective 
effects than IPost against reperfusion injury leading to great 
hopes in EPO as a pharmacological agent of postconditioning. 
This increased resistance to myocardial ischemia induced by 
EPO seems to be mediated by an enhanced phosphorylation of 
ERK1/2.
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Purpose — The Janus Kinase 2 / Signal Transducer and Activator 
of Transcription 3 (JAK2/STAT3) pathway is involved in protection 
of the adult heart against ischemia/reperfusion. STAT3 activation 
can result from phosphorylation on two sites: tyrosine 705 by 
JAKs and serine 727 mainly by Mitogen-Activated Protein Kinases 
(MAPKs). We have previously shown that, under basal conditions, 
STAT3 is inhomogeneously distributed and phosphorylated in atria, 
ventricle and out ow tract of the embryonic heart. However, to 
what extent the JAK2/STAT3 pathway contributes to the response 
of the developing heart to transient oxygen lack or oxidant stress 
remains unknown.
Methods — Hearts isolated from 4-day-old chick embryos 
were studied in vitro. In a  rst series of experiments, hearts 
were submitted to anoxia (30min) and reoxygenation (80min) 
with or without the antioxidant MPG (1mM). The time course 
of STAT3 phosphorylation on tyrosine (P-Tyr) and on serine 
(P-Ser) was determined by immunoblotting on ventricles 
removed at speci c time points. In a second series of 
experiments, hearts were exposed to H2O2 (1mM, 1 h) 
and STAT3 phosphorylation (P-Tyr and P-Ser) was assessed 
in atria, ventricle and out ow tract.
Results — In the ventricle, P-Tyr STAT3 was unchanged 
during anoxia but increased upon reoxygenation, reaching 
a peak (eightfold) after 1 h and returning to basal level after 
80min. P-Ser STAT3 slightly increased (x1.7) only after 1 h 
of reoxygenation. The peak of P-Tyr STAT3 was abolished 
by MPG. Exposure to H2O2 increased signi cantly P-Tyr 
STAT3 only in the ventricle (twofold) but had no effect on 
P-Ser STAT3 whatever the investigated region. Moreover, 
H2O2 suppressed atrial activity in 50 % of the hearts 
and atrioventricular conduction in 70 % of the hearts.
Conclusions — In the anoxic-reoxygenated ventricle of the 
embryonic heart STAT3 activation i) is ROS-dependent, ii) 
requires speci c phosphorylation on tyrosine site and iii) is 
probably independent of MAPKs. STAT3 could also contribute 
to the protection of the developing heart submitted to oxidant 
stress or transient anoxia.
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La compréhension des mécanismes physiologiques ainsi que leur 
retentissement global sur l’énergétique cardiaque en réponse 
à l’hypoxie chronique nécessite l’étude intégrée de modèles 
expérimentaux développant les symptômes adaptatifs observés lors 
des pathologies pulmonaires.
